Article

Reform Update: Some Question the Value of Value-Based Purchasing

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing.

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing. As physicians wait to see if their payments will be docked or boosted based on how they rank, health policy researchers are continuing to raise questions about how the program works.

The methodology the CMS adopted may lead to distorted comparisons, perverse incentives and may not achieve the desired goals, they warn.

Value-based purchasing is part of the quality incentive program established through the Patient Protection and Affordable Care Act to help drive down costs while promoting high-quality care for Medicare beneficiaries.

Read the full story here: http://bit.ly/1pMGyU3

Source: Modern Healthcare

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Nicolas Ferreyros, managing director, Community Oncology Alliance
Merrill H. Stewart, MD
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Hamlet Gasoyan, PhD
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo